Heart safety check for new asthma drug tezepelumab

NCT ID NCT06951867

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Nov 05, 2025 · Last updated May 14, 2026 · Updated 25 times

Summary

This study looks at whether tezepelumab, a medicine for severe asthma, increases the risk of serious heart problems like heart attack or stroke. It will follow over 16,000 teens and adults with severe asthma who take tezepelumab or standard treatment. Researchers will compare heart-related events between the two groups to understand the drug's safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Danish registries (access/analysis)
RECRUITING

Copenhagen, Denmark

Contact Email: •••••@•••••
French National Health Data System (SNDS)
RECRUITING

Paris, France

Contact Email: •••••@•••••
Healthcare Integrated Research Database (HIRD)
RECRUITING

Wilmington, Delaware, 19801, United States
Team Gesundheit GKV Claims data (SHI)
RECRUITING

Berlin, Germany

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARDIOVASCULAR EVENTS MACE MACE